These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 35017262)

  • 1. Identifying best modelling practices for tobacco control policy simulations: a systematic review and a novel quality assessment framework.
    Huang V; Head A; Hyseni L; O'Flaherty M; Buchan I; Capewell S; Kypridemos C
    Tob Control; 2023 Sep; 32(5):589-598. PubMed ID: 35017262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tobacco Control Policy Simulation Models: Protocol for a Systematic Methodological Review.
    Huang V; Head A; Hyseni L; O'Flaherty M; Buchan I; Capewell S; Kypridemos C
    JMIR Res Protoc; 2021 Jul; 10(7):e26854. PubMed ID: 34309577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for enhancing the implementation of school-based policies or practices targeting risk factors for chronic disease.
    Wolfenden L; Nathan NK; Sutherland R; Yoong SL; Hodder RK; Wyse RJ; Delaney T; Grady A; Fielding A; Tzelepis F; Clinton-McHarg T; Parmenter B; Butler P; Wiggers J; Bauman A; Milat A; Booth D; Williams CM
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011677. PubMed ID: 29185627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies to improve the implementation of workplace-based policies or practices targeting tobacco, alcohol, diet, physical activity and obesity.
    Wolfenden L; Goldman S; Stacey FG; Grady A; Kingsland M; Williams CM; Wiggers J; Milat A; Rissel C; Bauman A; Farrell MM; Légaré F; Ben Charif A; Zomahoun HTV; Hodder RK; Jones J; Booth D; Parmenter B; Regan T; Yoong SL
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012439. PubMed ID: 30480770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The global impact of tobacco control policies on smokeless tobacco use: a systematic review.
    Chugh A; Arora M; Jain N; Vidyasagaran A; Readshaw A; Sheikh A; Eckhardt J; Siddiqi K; Chopra M; Mishu MP; Kanaan M; Rahman MA; Mehrotra R; Huque R; Forberger S; Dahanayake S; Khan Z; Boeckmann M; Dogar O
    Lancet Glob Health; 2023 Jun; 11(6):e953-e968. PubMed ID: 37202029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of institutional smoking bans on reducing harms and secondhand smoke exposure.
    Frazer K; McHugh J; Callinan JE; Kelleher C
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD011856. PubMed ID: 27230795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of maximising the UK's tobacco control score on inequalities in smoking prevalence and premature coronary heart disease mortality: a modelling study.
    Allen K; Kypridemos C; Hyseni L; Gilmore AB; Diggle P; Whitehead M; Capewell S; O'Flaherty M
    BMC Public Health; 2016 Apr; 16():292. PubMed ID: 27036296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
    Ekpu VU; Brown AK
    Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential impact of policies and structural interventions in reducing cardiovascular disease and mortality: a systematic review of simulation-based studies.
    Uthman OA; Court R; Anjorin S; Enderby J; Al-Khudairy L; Nduka C; Mistry H; Melendez-Torres GJ; Taylor-Phillips S; Clarke A
    Health Technol Assess; 2023 Dec; ():1-32. PubMed ID: 38140927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a microsimulation economic model to evaluate the disease burden associated with smoking and the cost-effectiveness of tobacco control interventions in Latin America.
    Pichon-Riviere A; Augustovski F; Bardach A; Colantonio L;
    Value Health; 2011; 14(5 Suppl 1):S51-9. PubMed ID: 21839900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Portion, package or tableware size for changing selection and consumption of food, alcohol and tobacco.
    Hollands GJ; Shemilt I; Marteau TM; Jebb SA; Lewis HB; Wei Y; Higgins JP; Ogilvie D
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD011045. PubMed ID: 26368271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential effects of tobacco control in China: projections from the China SimSmoke simulation model.
    Levy D; Rodríguez-Buño RL; Hu TW; Moran AE
    BMJ; 2014 Feb; 348():g1134. PubMed ID: 24550245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Informing policy makers on the efficiency of population level tobacco control interventions in Asia: A systematic review of model-based economic evaluations.
    Tuvdendorj A; Du Y; Sidorenkov G; Buskens E; de Bock GH; Feenstra T
    J Glob Health; 2020 Dec; 10(2):020437. PubMed ID: 33403106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel microsimulation model of tobacco use behaviours and outcomes: calibration and validation in a US population.
    Reddy KP; Bulteel AJB; Levy DE; Torola P; Hyle EP; Hou T; Osher B; Yu L; Shebl FM; Paltiel AD; Freedberg KA; Weinstein MC; Rigotti NA; Walensky RP
    BMJ Open; 2020 May; 10(5):e032579. PubMed ID: 32404384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equity impact of population-level interventions and policies to reduce smoking in adults: a systematic review.
    Brown T; Platt S; Amos A
    Drug Alcohol Depend; 2014 May; 138():7-16. PubMed ID: 24674707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of public policies in reducing smoking prevalence: results from the Michigan SimSmoke tobacco policy simulation model.
    Levy DT; Huang AT; Havumaki JS; Meza R
    Cancer Causes Control; 2016 May; 27(5):615-25. PubMed ID: 26983616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational Models Used to Assess US Tobacco Control Policies.
    Feirman SP; Glasser AM; Rose S; Niaura R; Abrams DB; Teplitskaya L; Villanti AC
    Nicotine Tob Res; 2017 Nov; 19(11):1257-1267. PubMed ID: 28339561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of public policies in reducing smoking prevalence and deaths: the Argentina Tobacco Policy Simulation Model.
    Ferrante D; Levy D; Peruga A; Compton C; Romano E
    Rev Panam Salud Publica; 2007 Jan; 21(1):37-49. PubMed ID: 17439692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.